GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) shares crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $21.06 and traded as low as $20.04. GENMAB A/S/S shares last traded at $20.20, with a volume of 1,747,545 shares changing hands.
GENMAB A/S/S Trading Down 2.9 %
The company’s 50-day moving average is $21.06 and its two-hundred day moving average is $22.20.
About GENMAB A/S/S
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
See Also
- Five stocks we like better than GENMAB A/S/S
- How to Start Investing in Real Estate
- FedEx Delivers Another Crushing Blow to Its Stock Price
- ESG Stocks, What Investors Should Know
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Short Selling – The Pros and Cons
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
